Continuous Renal Replacement Therapy for Acute Respiratory Distress Syndrome
Author Information
Author(s): Zeng Siyao, Cui Shanpeng, Li Yue, Yao Zhipeng, Li Yunlong, Cao Yang, Wen Lianghe, Li Ming, Zheng Junbo, Wang Hongliang
Primary Institution: Harbin Medical University
Hypothesis
Does continuous renal replacement therapy (CRRT) benefit patients with acute respiratory distress syndrome (ARDS)?
Conclusion
Using CRRT in addition to conventional therapy may lower mortality rates and improve respiratory function in ARDS patients.
Supporting Evidence
- CRRT can reduce the mortality rate in ARDS patients.
- CRRT can decrease the incidence of ventilator-associated pneumonia.
- CRRT can shorten ICU length of stay and mechanical ventilation time.
- CRRT improves oxygenation index and partial pressure of oxygen at 72 hours.
- CRRT reduces inflammatory markers like TNF-α and IL-6.
Takeaway
This study found that a special treatment called CRRT can help sick people with breathing problems feel better and live longer.
Methodology
A systematic review and meta-analysis of 36 randomized controlled trials assessing the effects of CRRT on ARDS patients.
Potential Biases
Low-quality literature due to lack of blinding and allocation concealment in studies.
Limitations
The studies included were all from China, lacked blinding, and did not specify allocation concealment, leading to potential bias.
Participant Demographics
Patients diagnosed with ARDS, with or without acute kidney injury, from various studies conducted in China.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 0.30–0.53
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website